How to Treat Anorexia Nervosa: Therapy, Meds & More

Treating anorexia nervosa requires a combination of structured psychotherapy, medical monitoring, and nutritional rehabilitation, with medications playing a limited supporting role. No single pill or therapy cures the illness, and even the best-studied treatments produce full recovery in fewer than half of patients. The good news is that recovery is possible at any stage, and the treatment toolkit has expanded considerably in the past decade, with new approaches targeting everything from gut hormones to brain circuits.

Psychotherapy Is the Backbone

For adolescents, family-based treatment (FBT) is the first-line approach recommended by most clinical guidelines worldwide. FBT puts parents in charge of re-nourishing their child, with a therapist coaching the family through the process over roughly six months to a year. The logic is straightforward: the adolescent’s brain is too compromised by starvation to make sound food decisions, so the family temporarily takes over that job until weight is restored and cognitive function improves. Despite being the strongest evidence-based option for young people, FBT produces full recovery in only about 40% of cases, and less than half of adolescents reach full recovery by end of treatment.¹² That is a sobering number, but it is still the best we have for this age group, and many of the remaining patients do improve even if they do not meet strict recovery criteria.

For adults, the picture is more complicated because no single therapy has clearly pulled ahead of the pack. Three approaches have the most research behind them: enhanced cognitive behavioral therapy (CBT-E), the Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA), and specialist supportive clinical management (SSCM). A large network meta-analysis in The Lancet Psychiatry found that none of these interventions clearly outperformed standard clinical care on weight gain or eating-disorder symptoms, though CBT had a lower dropout rate compared to psychodynamic therapies.³ Dropout matters in anorexia treatment: if someone stays in therapy, the odds of improvement go up substantially.

CBT-E, which was originally developed for bulimia nervosa and then adapted for anorexia, focuses on the thought patterns and behaviors that maintain the disorder. In a multi-site study of adults who completed CBT-E, the average weight gain was about 7.5 kilograms, and roughly 60% of completers reached a healthy-range BMI.⁴ That “completers” caveat is important: one real-world implementation found that 69% of patients dropped out before finishing, and only about a quarter of all patients who started treatment met recovery criteria.⁵ Even for people with severe, long-standing illness, though, an intensive version of CBT-E produced healthy-range BMI in about 40% at one-year follow-up.⁶

MANTRA, developed at the Maudsley Hospital in London, takes a different angle. It targets the cognitive and emotional styles that keep anorexia locked in place, such as rigid thinking, fear of strong emotions, and social difficulties. A systematic review found MANTRA was effective at improving BMI, eating symptoms, and emotional state, though it did not consistently outperform other active treatments.⁷ The practical takeaway is that having several therapy options lets clinicians match an approach to the person. If someone does not respond to one therapy, switching to another is reasonable.

Nutritional Rehabilitation and Medical Monitoring

Restoring weight is not optional in anorexia treatment. Psychotherapy cannot work well in a starving brain, and many of the psychiatric symptoms that look like personality traits, such as obsessiveness, social withdrawal, and difficulty concentrating, improve substantially once weight is restored. But how fast and where to refeed has been a long-running clinical debate.

For years, hospitals started malnourished patients on very low calorie levels, gradually increasing over days or weeks, out of fear of refeeding syndrome, a dangerous shift in electrolytes that can cause heart failure. More recent research has pushed back on that cautious approach. A study of hospitalized adolescents found that starting on higher calorie levels shortened hospital stays by several days without increasing rates of dangerous electrolyte drops.⁸ A multicenter randomized trial confirmed this, showing that higher-calorie refeeding cut hospital stays by about four days and saved roughly $19,000 in charges per patient, again with no increase in adverse events.⁹ That said, clinicians still need to watch closely for refeeding complications in the most severely malnourished patients, particularly those under 70% of expected body weight.¹⁰

An important question for many families is whether treatment needs to happen in a hospital. Outpatient treatment is generally the preferred format for someone who is medically stable, even if the anorexia is severe. It is less disruptive to daily life, cheaper, and does not appear to produce worse long-term outcomes.¹¹ Systematic reviews comparing inpatient and outpatient settings have found no clear difference in outcomes, while both outpatient and day-program treatment were significantly cheaper.¹²¹³ Hospitalization remains necessary for medical emergencies, such as dangerously low heart rate, severe electrolyte imbalances, or acute psychiatric risk, but the evidence does not support keeping patients inpatient for months solely for weight restoration when outpatient alternatives exist.

Bone Health During and After Recovery

One of the most persistent medical consequences of anorexia is bone loss. Malnutrition and the loss of menstrual periods (in females) or low testosterone (in males) combine to weaken bones, sometimes producing osteoporosis in people still in their twenties. The single most effective treatment for this is weight restoration itself, which has the strongest impact on rebuilding bone density.¹⁴ Resumption of menstrual function appears to add further benefit.¹⁵

For adolescent girls whose periods have not returned, transdermal estrogen patches (rather than oral birth control pills, which pass through the liver and suppress a bone-building growth factor) may help preserve bone density during the recovery process.¹⁶ This is an area where clinicians need to be proactive, since bone loss can accumulate silently and may never be fully reversed even with full recovery.

What Medications Can and Cannot Do

If you are hoping for a medication that treats anorexia the way antidepressants treat depression, the honest answer is that it does not exist yet. Controlled trials of nearly every psychiatric medication have shown no benefit for the core illness when patients are still underweight.¹⁷ This failure likely has a biological explanation: starvation alters brain chemistry so fundamentally that drugs targeting serotonin or other neurotransmitters simply cannot gain traction in a depleted system.

Antidepressants, particularly SSRIs like fluoxetine, have shown no benefit during the acute underweight phase in randomized trials.¹⁸ However, there is limited evidence that SSRIs may help with relapse prevention and accompanying anxiety or depression once weight has been restored.¹⁹ The practical distinction matters: if your treatment team prescribes an antidepressant, it is likely targeting co-occurring symptoms rather than the anorexia itself, and it is more likely to help after some weight has been regained.

The one medication with a somewhat more encouraging evidence base is olanzapine, an atypical antipsychotic. A meta-analysis found that olanzapine produced a modest but statistically significant increase in BMI compared to placebo.²⁰ An earlier randomized trial found it led to faster weight gain and reduced obsessive thinking.²¹ Olanzapine is sometimes used off-label in adults with anorexia, though controlled research in adolescents remains limited.²² It is not a wonder drug, and the weight gain it produces is modest, but for some patients it takes enough of the edge off anxiety and obsessive food-related thoughts to make therapy more productive.

Experimental Drug Approaches

A handful of more unusual pharmacological strategies have been explored in small trials. Dronabinol, a synthetic form of THC (the active compound in cannabis), produced a small but statistically significant weight gain in a randomized trial of women with severe, long-standing anorexia, and was also associated with a modest increase in physical activity.²³²⁴ A ghrelin agonist called relamorelin, which mimics the appetite-stimulating hormone ghrelin, showed a trend toward weight gain over four weeks and significantly sped up stomach emptying (delayed gastric emptying is a common and uncomfortable symptom of anorexia).²⁵ Neither of these is ready for routine clinical use, but they represent efforts to target the biological machinery of hunger and metabolism rather than relying purely on willpower and behavioral change.

Psilocybin and Brain Stimulation

Psychedelic-assisted therapy has generated headlines, and a small open-label study published in Nature Medicine found that a single 25-milligram dose of psilocybin, given alongside psychological support, was safe and well tolerated in ten women with anorexia or partial-remission anorexia. There were no serious adverse events, and participants generally found the experience acceptable.²⁶ A broader review found preliminary evidence that psychedelic-assisted therapy may be effective for anorexia and bulimia, with studies and case reports involving ketamine, MDMA, psilocybin, and ayahuasca, though the evidence base is still tiny.²⁷ Larger controlled trials are underway, including a registered trial in Australia specifically designed to test psilocybin-assisted psychotherapy for treatment-resistant anorexia.²⁸ The rationale is appealing: anorexia involves rigid, inflexible thinking patterns, and psychedelics appear to temporarily loosen cognitive rigidity. But this is still very early-stage science, not something you can access as standard care.

Brain stimulation techniques, including repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), and deep brain stimulation (DBS), have also been explored, primarily in patients with severe anorexia combined with treatment-resistant depression. A systematic scoping review found that all three approaches showed some positive effects on depression in this population, with DBS data suggesting possible long-term weight gain, though the absence of controlled trials means natural improvement over time could partly explain the results.²⁹ DBS for anorexia involves surgically implanting electrodes in a brain area called the subcallosal cingulate; a phase 1 pilot trial reported improvements in mood and anxiety over 12 months of stimulation.³⁰ This is experimental neurosurgery for the most critically ill patients, not an approach that will become routine anytime soon, but it reflects how seriously researchers are searching for options when conventional treatments fail.

Relapse Prevention

Relapse is common in anorexia, and knowing when it is most likely can help you stay vigilant. A meta-analysis covering an average follow-up of about two and a half years found an average relapse rate of 37%. Two factors predicted relapse across studies: lower BMI at the end of treatment and higher depression scores before treatment.³¹ Another study found that the highest-risk window for full relapse was between months four and sixteen after completing a relapse prevention program, with the first four months relatively safe.³²

The practical implication is that stepping down from intensive treatment too abruptly is risky. Maintaining some form of ongoing support, whether therapy sessions, dietitian check-ins, or a structured relapse prevention program, for at least a year after weight restoration gives you a safety net during the highest-risk period. Making sure depression is treated aggressively and that weight is solidly in a healthy range before ending active treatment also appear to protect against falling back.

Managing Compulsive Exercise

Excessive or compulsive exercise is one of the trickiest symptoms to address, especially in athletes. The traditional approach of simply banning all exercise can backfire: it increases anxiety, damages the therapeutic relationship, and does not teach the person a healthier way to relate to movement. Newer approaches like Compulsive Exercise Activity Therapy (LEAP) integrate supervised, moderate physical activity into the treatment plan. A study found LEAP was more effective than standard care at reducing rigid, rule-driven exercise patterns.³³ For competitive athletes, treatment considerations include using mindfulness-based strategies alongside cognitive-behavioral techniques, incorporating more exercise variety, and using objective measures like wearable technology and self-reported fatigue to make training decisions rather than rigid calorie calculations.³⁴

The Role of Families and Caregivers

Anorexia does not happen in isolation, and families are often overwhelmed, frightened, and unsure how to help without making things worse. The New Maudsley Collaborative Care model teaches caregivers specific skills for supporting recovery: how to communicate effectively around meals, how to avoid inadvertently accommodating the illness, and how to manage their own emotional reactions, particularly the heightened tension and criticism that can develop in a household where someone is refusing to eat.³⁵ A recent study found that caregivers who completed this skills-based training showed large improvements in their caregiving skills and knowledge.³⁶ These gains in caregiver competence are associated with improvements in patient well-being, too, which makes intuitive sense: the person with anorexia spends far more hours at home than in a therapist’s office, and a well-equipped family environment supports recovery around the clock.

Treatment for Men

Anorexia in men is under-recognized and under-studied. Most clinical trials have included few or no male participants, which means the evidence base is built almost entirely on data from women. Men with anorexia tend to present somewhat differently: excessive exercise is more common than restrictive dieting as the primary behavior, body image distortion may center on muscularity rather than thinness, and medical complications can develop at higher body weights than the thresholds used for women.³⁷ Delayed help-seeking, feeling excluded by treatment services perceived as designed for women, and clinical tools calibrated to female presentations all create barriers. A gender-matched prospective study found that men who did receive treatment showed slightly better outcomes than women, suggesting that the issue is access and recognition rather than inherent treatment resistance.³⁸ Specialized treatment environments for men have also shown positive results.³⁹

Telehealth and Access

One of the biggest barriers to recovery is simple geography: eating disorder specialists are concentrated in urban areas, and many families face long drives or waitlists that stretch for months. The shift toward telehealth, accelerated by the pandemic, has begun to change this. A study of enhanced family-based treatment delivered virtually found that after 16 weeks, patients on weight restoration gained an average of about 11 pounds, with significant improvements in eating-disorder symptoms. Both patients and caregivers reported satisfaction with the virtual format.⁴⁰ A separate implementation study in rural settings found that telehealth-delivered FBT produced significant weight gains that were maintained at six-month follow-up, with over two-thirds of adolescents reaching weight restoration.⁴¹ Telehealth is not a perfect substitute for in-person care, particularly for the sickest patients who need medical monitoring, but it meaningfully expands who can get evidence-based treatment without uprooting their lives.

The Gut-Brain Connection

Emerging research has begun to explore whether the gut microbiome plays a role in anorexia and, by extension, whether manipulating it could be part of treatment. People with anorexia show distinct patterns of gut bacteria compared to healthy controls, and some research suggests probiotic supplementation can partially restore this imbalance.⁴² Separately, brain imaging research has found altered dopamine receptor activity in people recovered from anorexia, suggesting that the brain’s reward system may be wired differently in ways that make food less pleasurable and contribute to the characteristically rigid, reward-avoidant temperament of the disorder.⁴³ Neither of these findings has yet translated into a proven treatment, but they point toward a future where biological interventions, whether targeted probiotics, dopamine-modulating drugs, or something else, could complement the psychological and nutritional approaches that remain the current standard of care.